Copaxone 20 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FJL92
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,510
Award facts
- Contract value 100% obligated
- $10,510.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,510.43 to AmerisourceBergen Drug Corp for the supply of Copaxone 20 mg/ml syringes. The contract, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, carries firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen utilizes its comprehensive IDC with DLA to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare systems worldwide. Copaxone, a disease-modifying therapy for multiple sclerosis, represents one of the specialized medications delivered through this contract vehicle. The award demonstrates AmerisourceBergen's continued role as a primary pharmaceutical supplier to the Defense Health Agency and other federal healthcare systems, fulfilling the company's strategic position within DLA's Pharmaceutical Prime Vendor Global Program supporting defense medical supply chains.
Quick answers
Who was awarded contract SPE2DB25FJL92?
SPE2DB25FJL92 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FJL92 worth?
The government has obligated $10,510 on SPE2DB25FJL92.
Is contract SPE2DB25FJL92 an order under another contract?
Yes. SPE2DB25FJL92 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJL92 competed?
The extent of competition for SPE2DB25FJL92 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award